Departments of Obstetrics and Gynecology (L.B., S.S.-T., Z.A.B.-B., E.A.P.S.), Erasmus Medical Center, Rotterdam, the Netherlands.
General Medicine (J.E.R.v.L.), Erasmus Medical Center, Rotterdam, the Netherlands.
Circulation. 2019 Apr 2;139(14):1698-1709. doi: 10.1161/CIRCULATIONAHA.118.036632.
Angiogenic placental growth factor (PlGF) concentrations rise during pregnancy, peaking at the end of midpregnancy. Low PlGF concentrations during pregnancy are associated with pregnancy complications with recognized later-life cardiovascular risk. We hypothesized that low PlGF concentrations, especially in midpregnancy, identify not only a subset of women at risk for pregnancy complications but also women with greater cardiovascular risk factor burden after pregnancy regardless of pregnancy outcome.
In a population-based prospective cohort study of 5475 women, we computed gestational age-adjusted multiples of the medians of early pregnancy and midpregnancy PlGF concentrations. Information on pregnancy complications (preeclampsia, small for gestational age, and spontaneous preterm birth) was obtained from hospital registries. Six years after pregnancy, we measured maternal systolic and diastolic blood pressures, cardiac structure (aortic root diameter, left atrial diameter, left ventricular mass, and fractional shortening), carotid-femoral pulse wave velocity, and central retinal arteriolar and venular calibers. Blood pressure was also measured 9 years after pregnancy.
Women were on average 29.8 (SD, 5.2) years of age in pregnancy, were mostly European (55.2%), and 14.8% developed a pregnancy complication. Quartile analysis showed that especially women with midpregnancy PlGF in the lowest quartile (the low-PlGF subset) had a larger aortic root diameter (0.40 mm [95% CI, 0.08-0.73]), left atrial diameter (0.34 mm [95% CI, -0.09 to 0.78]), left ventricular mass (4.6 g [95% CI, 1.1-8.1]), and systolic blood pressure (2.3 mm Hg [95% CI, 0.93-3.6]) 6 years after pregnancy than women with the highest PlGF. Linear regression analysis showed that higher midpregnancy PlGF concentrations were associated with a smaller aortic root diameter (-0.24 mm [95% CI, -0.39 to -0.10]), smaller left atrial diameter (-0.75 mm [95% CI, -0.95 to -0.56]), lower left ventricular mass (-3.9 g [95% CI, -5.5 to -2.3]), and lower systolic blood pressure (-1.1 mm Hg [95% CI, -1.7 to -0.46]). These differences persisted after the exclusion of women with complicated pregnancies.
Women with low PlGF in midpregnancy have a greater aortic root diameter, left atrial diameter, and left ventricular mass and higher systolic blood pressure 6 and 9 years after pregnancy compared to women with higher PlGF, including women with uncomplicated pregnancies. The pathophysiological implications of lower PlGF concentrations in midpregnancy might provide insight into the identification of pathways contributing to greater cardiovascular risk factor burden.
血管生成胎盘生长因子(PlGF)在怀孕期间浓度升高,在妊娠中期末达到峰值。怀孕期间 PlGF 浓度低与妊娠并发症有关,这些并发症与公认的日后心血管风险相关。我们假设,低 PlGF 浓度,尤其是在妊娠中期,不仅可以识别出一部分有妊娠并发症风险的女性,还可以识别出那些即使妊娠结局良好但在妊娠后心血管危险因素负担更大的女性。
在一项基于人群的前瞻性队列研究中,我们对 5475 名女性进行了妊娠年龄调整的早期和中期妊娠 PlGF 浓度的倍数计算。妊娠并发症(子痫前期、胎儿生长受限和自发性早产)的信息来自医院登记处。在妊娠后 6 年,我们测量了母亲的收缩压和舒张压、心脏结构(主动脉根部直径、左心房直径、左心室质量和分数缩短)、颈动脉-股动脉脉搏波速度以及中央视网膜小动脉和小静脉的直径。在妊娠后 9 年,我们也测量了血压。
女性在妊娠时平均年龄为 29.8(标准差 5.2)岁,大多数为欧洲人(55.2%),14.8%发生了妊娠并发症。四分位分析显示,尤其是妊娠中期 PlGF 浓度处于最低四分位的女性(低 PlGF 亚组),其主动脉根部直径(0.40 毫米[95%置信区间:0.08-0.73])、左心房直径(0.34 毫米[95%置信区间:-0.09 至 0.78])、左心室质量(4.6 克[95%置信区间:1.1-8.1])和收缩压(2.3 毫米汞柱[95%置信区间:0.93-3.6])在妊娠后 6 年比 PlGF 最高的女性更大。线性回归分析显示,较高的妊娠中期 PlGF 浓度与主动脉根部直径较小(-0.24 毫米[95%置信区间:-0.39 至 -0.10])、左心房直径较小(-0.75 毫米[95%置信区间:-0.95 至 -0.56])、左心室质量较小(-3.9 克[95%置信区间:-5.5 至 -2.3])和收缩压较低(-1.1 毫米汞柱[95%置信区间:-1.7 至 -0.46])相关。这些差异在排除有复杂妊娠的女性后仍然存在。
与 PlGF 较高的女性(包括无复杂妊娠的女性)相比,妊娠中期 PlGF 浓度较低的女性,其主动脉根部直径、左心房直径和左心室质量更大,收缩压更高,在妊娠后 6 年和 9 年时均如此。妊娠中期 PlGF 浓度较低可能提示更大的心血管危险因素负担的发病机制途径,这可能为识别这些途径提供了线索。